XML 17 R6.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Common Stock (Class A and B)
Additional Paid-in-Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning of the period (in shares) at Dec. 31, 2024   55,492,000      
Beginning of the period at Dec. 31, 2024 $ (41,684) $ 56 $ 672,363 $ (6,420) $ (707,683)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 27,888   27,888    
Issuance of common stock upon exercise of stock options (in shares)   44,000      
Issuance of common stock upon exercise of stock options 631   631    
Issuance of common stock under employee stock purchase plan (in shares)   119,000      
Issuance of common stock under employee stock purchase plan 7,535   7,535    
Issuance of restricted stock units (in shares)   698,000      
Tax withholding related to net share settlements of stock-based compensation awards (in shares)   (138,000)      
Tax withholding related to net share settlements of stock-based compensation awards (12,922)   (12,922)    
Repurchases of Class A common stock (in shares)   (462,000)      
Repurchases of Class A common stock (40,118)   (40,118)    
Net income (loss) (21,371)       (21,371)
Other comprehensive (loss) income 4,306     4,306  
End of period (in shares) at Mar. 31, 2025   55,753,000      
End of period at Mar. 31, 2025 (75,735) $ 56 655,377 (2,114) (729,054)
Beginning of the period (in shares) at Dec. 31, 2024   55,492,000      
Beginning of the period at Dec. 31, 2024 (41,684) $ 56 672,363 (6,420) (707,683)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (40,771)        
Other comprehensive (loss) income 13,214        
End of period (in shares) at Jun. 30, 2025   55,844,000      
End of period at Jun. 30, 2025 (66,528) $ 56 675,076 6,794 (748,454)
Beginning of the period (in shares) at Mar. 31, 2025   55,753,000      
Beginning of the period at Mar. 31, 2025 (75,735) $ 56 655,377 (2,114) (729,054)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 28,467   28,467    
Issuance of common stock upon exercise of stock options (in shares)   123,000      
Issuance of common stock upon exercise of stock options 1,803   1,803    
Issuance of restricted stock units (in shares)   108,000      
Tax withholding related to net share settlements of stock-based compensation awards (in shares)   (8,000)      
Tax withholding related to net share settlements of stock-based compensation awards (569)   (569)    
Repurchases of Class A common stock (in shares)   (132,000)      
Repurchases of Class A common stock (10,002)   (10,002)    
Net income (loss) (19,400)       (19,400)
Other comprehensive (loss) income 8,908     8,908  
End of period (in shares) at Jun. 30, 2025   55,844,000      
End of period at Jun. 30, 2025 (66,528) $ 56 675,076 6,794 (748,454)
Beginning of the period (in shares) at Dec. 31, 2025   56,320,000      
Beginning of the period at Dec. 31, 2025 (5,436) $ 57 720,923 7,436 (733,852)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 28,607   28,607    
Issuance of common stock upon exercise of stock options (in shares)   44,000      
Issuance of common stock upon exercise of stock options 729   729    
Issuance of common stock under employee stock purchase plan (in shares)   140,000      
Issuance of common stock under employee stock purchase plan 8,052   8,052    
Issuance of restricted stock units (in shares)   749,000      
Tax withholding related to net share settlements of stock-based compensation awards (in shares)   (122,000)      
Tax withholding related to net share settlements of stock-based compensation awards (8,662)   (8,662)    
Repurchases of Class A common stock (in shares)   (763,000)      
Repurchases of Class A common stock (50,000)   (50,000)    
Net income (loss) 18,996       18,996
Other comprehensive (loss) income (4,901)     (4,901)  
End of period (in shares) at Mar. 31, 2026   56,368,000      
End of period at Mar. 31, 2026 (12,615) $ 57 699,649 2,535 (714,856)
Beginning of the period (in shares) at Dec. 31, 2025   56,320,000      
Beginning of the period at Dec. 31, 2025 $ (5,436) $ 57 720,923 7,436 (733,852)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 68,309        
Net income (loss) $ 32,438        
Other comprehensive (loss) income (7,148)        
End of period (in shares) at Jun. 30, 2026   54,091,000      
End of period at Jun. 30, 2026 (97,076) $ 55 603,995 288 (701,414)
Beginning of the period (in shares) at Mar. 31, 2026   56,368,000      
Beginning of the period at Mar. 31, 2026 (12,615) $ 57 699,649 2,535 (714,856)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 29,751   29,751    
Issuance of common stock upon exercise of stock options (in shares)   25,000      
Issuance of common stock upon exercise of stock options 322   322    
Issuance of restricted stock units (in shares)   227,000      
Tax withholding related to net share settlements of stock-based compensation awards (in shares)   (37,000)      
Tax withholding related to net share settlements of stock-based compensation awards (1,984)   (1,984)    
Repurchases of Class A common stock (in shares)   (2,492,000)      
Repurchases of Class A common stock (123,745) $ (2) (123,743)    
Net income (loss) 13,442       13,442
Other comprehensive (loss) income (2,247)     (2,247)  
End of period (in shares) at Jun. 30, 2026   54,091,000      
End of period at Jun. 30, 2026 $ (97,076) $ 55 $ 603,995 $ 288 $ (701,414)